Skip to main content

Advertisement

Log in

Lymph node ratio in lateral neck is an independent risk factor for recurrence-free survival in papillary thyroid cancer patients with positive lymph nodes

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Background

The purpose of this study was to explore the impact of the lymph node ratio on prognosis in papillary thyroid cancer patients with lymph node metastasis.

Methods

Data from papillary thyroid cancer patients with positive nodes who were initially treated at our institution during 2015–2016 were analysed. Univariate and multivariate Cox proportional hazard models were adopted to predict prognostic factors. A receiver operating characteristic (ROC) curve was used to find the best cut-off value of the lymph node ratio (LNR). Kaplan–Meier curves were used to show the relationship between the LNR in the lateral neck and recurrence-free survival.

Results

The median follow-up time was 64.6 months, and recurrence occurred in 16 of 662 patients (2.27%). Univariate analysis showed that male sex, primary tumour size (>17 mm), visible extrathyroidal extension, LNR in the central neck (>0.5), LNR in the lateral neck (>0.10), and visible extranodal extension were significantly correlated with recurrence-free survival (RFS) (p < 0.05). Multivariate analysis using the Cox proportional hazards model showed that the LNR in the lateral neck was an independent risk factor for RFS (p = 0.039; HR 14.76).

Conclusion

The LNR in the lateral neck was an independent risk factor for recurrence-free survival. For patients with a high lymph node ratio in the lateral neck, more frequent follow-up might be needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. H. Lim, S.S. Devesa, J.A. Sosa, D. Check, C.M. Kitahara, Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA 317, 1338–1348 (2017)

    Article  PubMed  PubMed Central  Google Scholar 

  2. Y. Huang, S. Qu, G. Zhu, F. Wang, R. Liu et al. BRAF V600E mutation-assisted risk stratification of solitary intrathyroidal papillary thyroid cancer for precision treatment. J. Natl Cancer Inst. 110, 362–370 (2018)

    Article  PubMed  Google Scholar 

  3. A. Eskander, M. Merdad, J.L. Freeman, I.J. Witterick, Pattern of spread to the lateral neck in metastatic well-differentiated thyroid cancer: a systematic review and meta-analysis. Thyroid 23, 583–592 (2013)

    Article  PubMed  Google Scholar 

  4. American Thyroid Association Surgery Working Group, American Association of Endocrine Surgeons, American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society, S.E. Carty, D.S. Cooper, G.M. Doherty, Q.Y. Duh, R.T. Kloos, S.J. Mandel, G.W. Randolph, B.C. Jr Stack, D.L. Steward, D.J. Terris, G.B. Thompson, R.P. Tufano, R.M. Tuttle, R. Udelsman, Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 19, 1153–1158 (2009)

  5. B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26, 1–133 (2016)

    Article  PubMed  PubMed Central  Google Scholar 

  6. Y. Ito, T. Kudo, Y. Takamura, K. Kobayashi, A. Miya et al. Lymph node recurrence in patients with N1b papillary thyroid carcinoma who underwent unilateral therapeutic modified radical neck dissection. World J. Surg. 36, 593–597 (2012)

    Article  PubMed  Google Scholar 

  7. B.C. Stack Jr., R.L. Ferris, D. Goldenberg, M. Haymart, A. Shaha et al. American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid 22, 501–508 (2012)

    Article  PubMed  Google Scholar 

  8. J.H. Vas Nunes, J.R. Clark, K. Gao, E. Chua, P. Campbell et al. Prognostic implications of lymph node yield and lymph node ratio in papillary thyroid carcinoma. Thyroid 23, 811–816 (2013)

    Article  PubMed  Google Scholar 

  9. J.E. Noel, L.A. Orloff, Recognizing persistent disease in well-differentiated thyroid cancer and association with lymph node yield and ratio. Otolaryngol. Head. Neck Surg. 162, 50–55 (2020)

    Article  PubMed  Google Scholar 

  10. C.W. Lee, J.L. Roh, G. Gong, K.J. Cho, S.H. Choi et al. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck. Ann. Surg. Oncol. 22, 117–124 (2015)

    Article  PubMed  Google Scholar 

  11. U.M. Yuksel, S. Turanli, Y. Acar, U. Berberoglu, The prognostic factors for clinical N1b patients in thyroid papillary carcinoma. J. Cancer Res. Ther. 15, 681–685 (2019)

    Article  CAS  PubMed  Google Scholar 

  12. H. Lindfors, C. Ihre Lundgren, J. Zedenius, C.C. Juhlin, I. Shabo, The clinical significance of lymph node ratio and Ki-67 expression in papillary thyroid cancer. World J. Surg. 45, 2155–2164 (2021)

    Article  PubMed  PubMed Central  Google Scholar 

  13. J. Lee, C.H. Kim, I.K. Min, S. Jeong, H. Kim et al. Detailed characterization of metastatic lymph nodes improves the prediction accuracy of currently used risk stratification systems in N1 stage papillary thyroid cancer. Eur. J. Endocrinol. 183, 83–93 (2020)

    Article  CAS  PubMed  Google Scholar 

  14. S.H. Nam, J.L. Roh, G. Gong, K.J. Cho, S.H. Choi et al. Nodal factors predictive of recurrence after thyroidectomy and neck dissection for papillary thyroid carcinoma. Thyroid 28, 88–95 (2018)

    Article  PubMed  Google Scholar 

  15. J.L. Roh, J.W. Park, J. Jeong, G. Gong, K.J. Cho et al. Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma. J. Surg. Oncol. 116, 450–458 (2017)

    Article  CAS  PubMed  Google Scholar 

  16. C.M. Zheng, Y.B. Ji, C.M. Song, M.H. Ge, K. Tae, Number of metastatic lymph nodes and ratio of metastatic lymph nodes to total number of retrieved lymph nodes are risk factors for recurrence in patients with clinically node negative papillary thyroid carcinoma. Clin. Exp. Otorhinolaryngol. 11, 58–64 (2018)

    Article  PubMed  Google Scholar 

  17. S.Y. Choi, J.K. Cho, J.H. Moon, Y.I. Son, Metastatic lymph node ratio of central neck compartment has predictive values for locoregional recurrence in papillary thyroid microcarcinoma. Clin. Exp. Otorhinolaryngol. 9, 75–79 (2016)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Y. Kim, J.L. Roh, G. Gong, K.J. Cho, S.H. Choi et al. Risk factors for lateral neck recurrence of N0/N1a papillary thyroid cancer. Ann. Surg. Oncol. 24, 3609–3616 (2017)

    Article  PubMed  Google Scholar 

  19. L.Y. Wang, F.L. Palmer, I.J. Nixon, R.M. Tuttle, J.P. Shah et al. Lateral neck lymph node characteristics prognostic of outcome in patients with clinically evident N1b papillary thyroid cancer. Ann. Surg. Oncol. 22, 3530–3536 (2015)

    Article  PubMed  PubMed Central  Google Scholar 

  20. H. Hei, Y. Song, J. Qin, Individual prediction of lateral neck metastasis risk in patients with unifocal papillary thyroid carcinoma. Eur. J. Surg. Oncol. 45, 1039–1045 (2019)

    Article  PubMed  Google Scholar 

Download references

Funding

This study was funded by Henan Health Commission (grant number 2018020490).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hu Hei.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Luo, Z., Hei, H., Qin, J. et al. Lymph node ratio in lateral neck is an independent risk factor for recurrence-free survival in papillary thyroid cancer patients with positive lymph nodes. Endocrine 78, 484–490 (2022). https://doi.org/10.1007/s12020-022-03173-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-022-03173-x

Keywords

Navigation